Technical update on treatment optimization: use of efavirenz during pregnancy: a public health perspective : June 2012

Simple item page
dc.coverageGeneva
dc.creatorWorld Health Organization
dc.date2012-06-19T15:29:02Z
dc.date2012-06-19T15:29:02Z
dc.date2012-06-19
dc.date.accessioned2026-08-03T13:28:54Z
dc.description17 p.
dc.formatapplication/pdf
dc.identifier9789241503792
dc.identifierhttps://iris.who.int/handle/10665/70920
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/260421
dc.languageEnglish
dc.languageEspañol
dc.languageen
dc.languagees
dc.publisherWorld Health Organization
dc.subjectHIV Infections
dc.subjectAnti-HIV Agents
dc.subjectAnti-Retroviral Agents
dc.subjectBenzoxazines
dc.subjectPregnancy
dc.subjectInfectious Disease Transmission, Vertical
dc.subjectTreatment Outcome
dc.subjectDrug therapy
dc.subjectAdverse effects
dc.subjectPrevention and control
dc.titleTechnical update on treatment optimization: use of efavirenz during pregnancy: a public health perspective : June 2012
dc.titleActualización técnica sobre la optimización del tratamiento : uso de efavirenz durante el embarazo : unaperspectiva de salud pública : Junio del 2012
dc.typePublications

Files

Collections

WHO IRIS